Intro


THE FUTURE OF DIGITAL MOLECULAR Dx

 

SCROLL DOWN

Intro


THE FUTURE OF DIGITAL MOLECULAR Dx

 

REAGENT-FREE POINT OF CARE DIGITAL DIAGNOSTIC PLATFORM

SIME Dx was founded by a world-renowned Neonatologist and a foremost mathematician in 2008 to realise the potential of photonics and machine learning in clinical diagnostics


DMDx is a point of care diagnostic platform that can measure multiple biomarkers from a single fluid sample in real-time. Creating a biochemical profile of a patient at that moment in time to deliver precise diagnostic results to clinicians in critical moments.